P4‐380: BACE Inhibitor Verubecestat (MK‐8931): Baseline Characteristics for Participants Enrolled in the Phase II/III Epoch Alzheimer'S Disease Trial. (1st July 2016)

Record Type:
Journal Article
Title:
P4‐380: BACE Inhibitor Verubecestat (MK‐8931): Baseline Characteristics for Participants Enrolled in the Phase II/III Epoch Alzheimer'S Disease Trial. (1st July 2016)
Main Title:
P4‐380: BACE Inhibitor Verubecestat (MK‐8931): Baseline Characteristics for Participants Enrolled in the Phase II/III Epoch Alzheimer'S Disease Trial
Authors:
Egan, Michael
Voss, Tiffini
Mo, Yi
Mukai, Yuki
Furtek, Christine
Kost, James
Aisen, Paul S.
Cummings, Jeffrey L.
Tariot, Pierre N.
Vellas, Bruno
Michelson, David
Abstract:
Is Part Of:
Alzheimer's & dementia. Volume 12:Supplement 7S(2014)Part 24
Journal:
Alzheimer's & dementia
Issue:
Volume 12:Supplement 7S(2014)Part 24
Issue Display:
Volume 12, Issue 7, Part 24 (2016)
Year:
2016
Volume:
12
Issue:
7
Part:
24
Issue Sort Value:
2016-0012-0007-0024
Page Start:
P1183
Page End:
P1183
Publication Date:
2016-07-01
Subjects:
Alzheimer's disease -- Periodicals
Alzheimer Disease -- Periodicals
Dementia -- Periodicals
Démence
Maladie d'Alzheimer
Périodique électronique (Descripteur de forme)
Ressource Internet (Descripteur de forme)
616.83
Journal URLs:
http://www.sciencedirect.com/science/journal/15525260 ↗
http://www.elsevier.com/journals ↗
DOI:
10.1016/j.jalz.2016.07.126 ↗
Languages:
English
ISSNs:
1552-5260
Deposit Type:
Legaldeposit
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:
British Library DSC - 0806.255333
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:
13228.xml